Mounjaro®
Starting from £179.99/mo
Start journey Learn moreUsing steroids alongside semaglutide raises real, practical questions about how the two interact — on blood sugar, on appetite, and on how well the medicine works. Semaglutide is a prescription-only GLP-1 receptor agonist licensed in the UK for weight management, and the combination with corticosteroids is something prescribers consider carefully. This page explains the key factors, what the clinical picture looks like, and what that means for your decision. A prescriber assesses your full medical history before any treatment is approved; this page is educational, not a substitute for that assessment.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
When people ask about steroids and semaglutide, there is often an assumption that all steroids behave the same way. They don't. Anabolic steroids, topical creams, inhaled corticosteroids, and systemic oral or intravenous prednisolone sit in very different clinical categories. The concern that is most clinically relevant centres on systemic corticosteroids, medicines like prednisolone, dexamethasone, or hydrocortisone taken in meaningful doses for conditions such as inflammatory bowel disease, rheumatoid arthritis, asthma flare-ups, or autoimmune conditions.
Systemic corticosteroids raise blood glucose by stimulating the liver to produce more sugar and by reducing insulin sensitivity in muscle and fat cells. For someone using semaglutide, which works partly by improving the body's response to insulin and reducing appetite, a concurrent corticosteroid can blunt those effects. The degree to which this happens depends on the steroid dose and how long it is taken. A short course of prednisolone for a chest infection is a very different clinical picture from long-term maintenance therapy.
Inhaled steroids for asthma or topical steroids for a skin condition carry far lower systemic absorption and are much less likely to affect blood glucose significantly. The semaglutide overview on this site covers how semaglutide works in more detail, which provides useful context here. If you take a systemic steroid regularly, telling your prescriber is not optional, it directly shapes whether, and at what dose, semaglutide is appropriate for you.
The overlap between steroids and Wegovy is most discussed in the context of blood glucose. Semaglutide 2.4mg, licensed in the UK as Wegovy for weight management, was studied in the STEP 1 trial published in the New England Journal of Medicine, and participants with active uncontrolled medical conditions were excluded. Real-world use is more varied.
When corticosteroids push blood glucose up, particularly after meals, a prescriber may need to monitor more closely, adjust timing, or reconsider the dose of either medicine. This is not a reason to avoid semaglutide if it is otherwise appropriate, it is a reason to make sure the prescriber knows the full picture. People on long-term steroids for chronic conditions are sometimes also at higher risk of developing type 2 diabetes or already have steroid-induced hyperglycaemia. Semaglutide's glucose-lowering properties can in some circumstances be genuinely helpful in that context, but that is a clinical judgement, not a self-directed one.
If you are curious about whether you can take steroids with semaglutide specifically, that page goes into the eligibility and prescriber-review process in more detail. The short answer is: it depends on what steroid, at what dose, and your wider health. Worth a proper conversation.
There is a separate, often overlooked consideration. Semaglutide slows gastric emptying, this is part of how it reduces appetite and aids weight loss. For most people this is well tolerated. But it does mean that medicines taken orally around the same time may be absorbed more slowly or unpredictably than usual.
For oral corticosteroids, the clinical significance is generally considered modest, but it is part of the picture a prescriber needs to factor in. The NHS medicines page for semaglutide notes that you should tell your prescriber and pharmacist about all medicines you take, and this applies directly here. Timing of oral medicines relative to semaglutide can sometimes be adjusted, but the right approach is prescriber-led, not guesswork.
There is also a question some people raise about whether Wegovy itself is a steroid, it is not. Semaglutide is a GLP-1 receptor agonist with no structural relationship to corticosteroids or anabolic steroids, and people also sometimes ask about how semaglutide interacts with erectile dysfunction, given that both weight and hormonal factors can affect sexual health. It works on gut hormone pathways, not the hormonal mechanisms that steroids affect. It is a reasonable question, and the answer is simply: no, they are different classes entirely.
The decision about whether to use Wegovy when you are also on a steroid is not one to make by weighing up forum posts. The practical framework is straightforward: be transparent with both the clinician managing your steroid and whoever is assessing you for semaglutide. Those two conversations may need to happen in parallel.
At nume, every consultation is reviewed personally by a GPhC-registered Independent Prescriber, a real clinician reading your answers, not an automated triage tool. If you list a current steroid on your consultation form, that information is reviewed in context. You can read more about our clinical team and how oversight works. The prescriber may approve treatment, suggest a different approach, or ask a follow-up question. What they won't do is ignore a relevant medicine in your history.
If you have questions about weight management treatment more broadly, our weight loss treatment overview covers the licensed options and how they compare. For the wider side-effect picture with semaglutide, including things patients tell us they weren't expecting (like cold hands) those are covered in their own pages too. When you're ready to talk through your situation properly, speak to our prescribers through a free consultation.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.